Azure Minerals Ltd (ASX:AZS) has intercepted a very broad zone of high-grade nickel sulphide during resource definition drilling at the Ridgeline deposit, part of its Andover Project in the West Pilbara region of Western Australia, its highest-grade intersection to date.
Hole ANDD0177, the last in the current diamond drill program, hit 18.2 metres at 1.93% nickel, 0.65% copper and 0.08% cobalt from 508.2 metres, including 9.3 metres at 2.58% nickel, 0.75% copper and 0.10% cobalt from 510.5 metres.
Frontier Energy Ltd (ASX:FHE)’s Bristol Springs Renewable Energy Project (BSSP) has been awarded lead agency status by the Western Australian Government, under a program administered by the Department of Jobs, Tourism, Science and Innovation (JTSI).
Lead agency case management support is only awarded to projects, such as BSSP, that are of significance to the state.
Power Nickel Inc (TSX-V:PNPN) has raised C$4,192,500 after completing an over-subscribed private placement of 13,750,000 flow-through (FT) units at a price of $0.20 per FT unit and 14,425,000 non-flow-through (NFT) units at a price of $0.10 per NFT unit.
In a statement, CEO Terry Lynch said: “With the new financing we have expanded our drill program and now plan to keep drilling through mid-December and start up again in mid-January.”
Endeavour Mining PLC (LSE:EDV, TSX:EDV, OTCQX:EDVMF) is still a “top pick” among senior gold producers of analysts at Canaccord Genuity (TSX:CF, LSE:CF) after the company announced an initial three-million-ounce resource at its Tanda-Iguela project in Côte D’Ivoire.
The firm reiterated a Buy rating and a price target of C$40. Endeavour shares traded 1% higher at $27.42 Tuesday morning.
Analysts at Liberum Capital have reiterated a 'buy' rating on Emmerson PLC (AIM:EML, OTC:EMSNF) following news the firm has signed a 10-year ‘take-or-pay’ offtake agreement.
The Memoranda of Understanding (MOUs) with traders Keytrade and Hexagon Group is over 65% of MOP (muriate of potash) and 50% of salt production from Emmerson’s best in-class Khemisset potash project in Morocco.
Nextech AR Solutions Corp. (CSE:NTAR, OTCQB:NEXCF) said its subsidiary Map D has signed 25 new contracts so far this month, and hired several key executives as it positions itself for triple digit growth in 2023.
Map D is an event technology company that uses augmented reality (AR) and extended reality (XR) experiences, which is becoming an integral part of the Nextech Event Solutions brand.
G Mining Ventures Corp (TSX-V:GMIN, OTCQX:GMINF) has announced that its 100%-owned Tocantinzinho (TZ) Gold Project currently under construction in the state of Pará in Brazil remains on track and on budget for commercial production in the second half of 2024.
"Since making the formal construction decision in September, we have continued to make excellent progress on all fronts on our TZ project,” G Mining president and CEO Louis-Pierre Gignac said in a progress update.
Helium One Global Ltd (AIM:HE1, OTCQB:HLOGF) said it has changed rig supplier after legal complications, but still is targeting a spud date at the Rukwa licence in Tanzania in the first quarter of next year.
With the company believing legal issues around the previously announced Predator rig would have had an impact on its availability, it has now signed a memorandum of understanding with Exalo Drilling, an onshore drilling arm of Poland’s Orlen Group.
Anglo Asian Mining PLC (AIM:AAZ, OTC:AGXKF), the AIM-listed gold, copper and silver producer focused on Azerbaijan, has announced the start of an expansion of its flotation plant, which will be doubled in capacity, and provide additional operational flexibility.
The company said the expansion forms part of an increase in throughput capacity to process ore from new mines in the short and medium term. This will begin with Zafar, which is due to commence production in H2 2023. This will support the company's ambition to become a mid-tier miner producing over 100,000 gold equivalent ounces per annum, it added.
Condor Gold PLC (AIM:CNR, TSX:COG, OTC:CNDGF) said it has appointed Hannam and Partners to seek a buyer for the assets of the company. Condor recently completed a bankable feasibility study on the La India open-pit gold project in Nicaragua.
"Condor Gold has de-risked the La India gold project to a near construction-ready status, with an 18-month construction period from receipt of project financing,” said Mark Child, chief executive of Condor Gold in a statement.
Skye Bioscience Inc (OTCQB:SKYE) has announced that it will present a corporate overview at the RHK 2022 Disruptive Growth Conference being held December 5-6, 2022, at the offices of Reed Smith in New York City. Punit Dhillon, the company's chief executive officer and chair, will present on Monday, December 5, 2022, at 2.00pm ET. Dhillon and other representatives from the company will also be available for one-on-one meetings at the conference. The presentation will be available via webcast and archived in the News & Events section of Skye's investor relations website for a period of 90 days. Interested parties can register to watch the virtual presentation via the following link: https://wsw.com/webcast/rhk2/register.aspx?conf=rhk2&page=skye&url=https://wsw.com/webcast/rhk2/skye/1620612
Numinus Wellness Inc. (TSX:NUMI, OTC:LKYSF) has announced that Payton Nyquvest, its founder and CEO, will participate in a Water Tower Research Fireside Chat on Thursday, December 8, 2022, at 11.00am ET / 8.00am PT. The discussion will focus on key takeaways from Numinus' Q4 and Year End 2022 Results, including contributions from the acquisition of Novamind; expectations for 2023 and beyond; and upcoming catalysts for Numinus. Investors and other persons interested in participating, can register via the following link: https://us06web.zoom.us/webinar/register/WN_uEg8uOG9SXmpX2z-EyeDeQ. For more information about the event, or to schedule a one-on-one meeting with Numinus' management, interested parties can send an email to invest@numinus.com.
New Pacific Metals (TSX:NUAG, NYSE:NEWP) announced it has filed a technical report entitled "Carangas Project Technical Report" with an effective date of June 16, 2022.A copy of the Technical Report is available under the company's profile on SEDAR at www.sedar.com, on Edgar at www.sec.gov, and on the company's website at www.newpacificmetals.com.
Outlook Therapeutics Inc (NASDAQ:OTLK) announced that Russ Trenary, President and Chief Executive Officer of Outlook Therapeutics, will present in a fireside chat at the virtual BTIG Ophthalmology Day on November 29, 2022 at 12:30 PM ET. In addition to the presentation, management will be available to participate in virtual one-on-one meetings with qualified members of the investor community who are registered to attend the conference. BTIG hosted events are intended for prospective and existing BTIG clients only. To listen to the live event, please contact your BTIG representative with interest.
Todos Medical Ltd. (OTCQB:TOMDF) announced that company representatives will attend World Antiviral Congress 2022, taking place between 28th of November, 2022 – 1st of December, 2022 at Loews Coronado Bay Resort, San Diego.
Revive Therapeutics Ltd (CSE:RVV, OTCQB:RVVTF) announced that the U.S. Food & Drug Administration has responded that a Type C meeting would be recommended to discuss the overall development plan and the latest revised endpoints for Revive’s Phase 3 clinical trial of Bucillamine. The FDA has now requested additional information, which would include clinical data, for them to agree on the study’s revised endpoints. Revive plans to go over with the FDA the overall development plan for Bucillamine in COVID-19 and further review the Pre-Dose selection data that would support the appropriate endpoints. Additional secondary endpoints may include the time to the polymerase chain reaction resolution, clinical outcome (death or hospitalization), disease severity, supplemental oxygen use, and progression of COVID-19. Should the FDA agree with the revised protocol, the Data Safety Monitoring Board will then review the completed Post-Dose selection data of approximately 500 subjects in the context of the new primary endpoint. The DSMB may recommend continuing the study if there is a trend toward achieving statistical significance, halting the study early due to statistical significance likely not going to be met, or halting the study early due to positive efficacy showing statistical significance.
AmeraMex International (OTCQB:AMMX) has rescheduled its conference call to review the company’s financials for the third quarter and nine-month period ending September 30, 2022. A news release with dial-in information for the company’s conference call will be issued “as soon as possible,” according to a release.